MedPath

A study to compare the effectiveness of Mustasadhita Takra Basti and Takra Basti in Grahani/ Irritable Bowel Syndrome.

Phase 3
Conditions
Health Condition 1: K582- Mixed irritable bowel syndrome
Registration Number
CTRI/2023/08/056529
Lead Sponsor
Dr Ishwarakeerthi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

? Subjects between the age group of 21 – 65 years irrespective of gender, religion, occupation and socioeconomic status.

? Subjects fit for Basti.

? Subjects fulfilling the Rome IV diagnostic criteria for IBS.

? Subjects who are willing to give a written consent for the treatment

Exclusion Criteria

? Subjects below 21 years and above 65 years of age.

? Subjects unfit for Basti.

? Condition associated with inflammatory bowel disease, and other systemic illnesses that interfere with the treatment protocol.

? Pregnant and lactating women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Baddha Mala Pravritti, Drava Mala Pravritti, Muhur Muhur Mala Pravritti, Gas or Flatulence, Udara Shoola or Discomfort, Amayukta Mala Pravritti or Mucus in stoolTimepoint: 1st, 9th & 28th day
Secondary Outcome Measures
NameTimeMethod
ilTimepoint: Nil
© Copyright 2025. All Rights Reserved by MedPath